BDRX dilution watch: offerings and filings
BDRX (Biodexa Pharmaceuticals Plc) filed a new prospectus supplement (424B) on Wednesday, October 14, 2026 (F-1). Below is every offering event for the name in the last 60 days, newest first, and its Momo Meter alert history: 46 alerts in 90 days, last Oct 14, 5:09 PM.
| Date | Event | Momo Meter alerts, 90 days |
|---|---|---|
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 14, 2026 | New 424B filed a new prospectus supplement (424B), F-1, shelf | 46 last Oct 14, 5:09 PM |
| Oct 6, 2026 | Priced priced an offering, F-1, shelf | 46 last Oct 14, 5:09 PM |
| Sep 30, 2026 | Effective registration went effective, F-1, shelf | 46 last Oct 14, 5:09 PM |
| Sep 24, 2026 | New filing filed a new registration, F-1, shelf | 46 last Oct 14, 5:09 PM |
| Sep 11, 2026 | Priced priced an offering, F-1, shelf | 46 last Oct 14, 5:09 PM |
| Sep 11, 2026 | Priced priced an offering, F-1, shelf | 46 last Oct 14, 5:09 PM |
| Sep 11, 2026 | Priced priced an offering, F-1, shelf | 46 last Oct 14, 5:09 PM |
| Sep 11, 2026 | Priced priced an offering, F-1, shelf | 46 last Oct 14, 5:09 PM |
A registration (S-1 or S-3) is permission to sell new shares later; effective means the SEC cleared it; a pricing or a 424B supplement means shares are being sold now; an MEF adds shares to a sale in progress. New shares sold into the market dilute existing holders.